corresponding to the α-Gal epitope (Galα1-3Galβ1-4GlcNAc) that is the target of naturally occurring human anti-Gal antibodies and is central to xenotransplantation and anti-Gal immunology research
Viosterol-d6
enzymatic cleavage releases 4-methylumbelliferone
C21H36N2O14 / 540
5-Trihydroxy-6-[1-(isopropylamino-methyl)-2-(naphthalen-1-yloxy)-ethoxy]-tetrahydro-pyran-2-carboxylic acid
SI040140: Dolutegravir-d3 Pack Size:5 mg corresponding to the α-Gal epitopeC20H6D3F2N3O5 422. 4 HIV Infection Dolutegravir d3 Tivicay d3; (4R,12aS) N (2,4 difluorobenzyl) 7 hydroxy 4 methyl 6,8 dioxo 3,4,6,8,12,12a hexahydro 2H pyrido[1',2',4,5]pyrazino[2,1 b][1,3]oxazine 9 carboxamide d3